Indivior to Report First Quarter 2026 Financial Results and Host Webcast on April 30th
Indivior Pharmaceuticals will release its first quarter 2026 financial results on April 30, 2026, followed by a live webcast presentation by CEO Joe Ciaffoni and other executives. The company is a leader in long-acting injectable treatments for opioid use disorder and emphasizes its commitment to advancing treatments and understanding of OUD.